Consun Pharmaceutical Group Limited

HKEX:1681.HK

8.51 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 1,268.5491,470.4361,119.6791,346.122993.5281,158.134886.526986.974765.856787.22941.036974.95869.023890.874769.356771.636451.852443.83387.278410.461320.222343.375228.39142.941114.45114.45114.45114.45
Cost of Revenue 321.026385.174283.263321.301255.437292.038225.286236.893194.266212.957253.894242.564216.983244.681187.154217.41795.04884.13876.40488.47370.44369.50850.02329.88327.77827.77827.77827.778
Gross Profit 947.5231,085.262836.4161,024.821738.091866.096661.24750.081571.59574.263687.142732.386652.04646.193582.202554.219356.804359.692310.874321.988249.779273.867178.367113.05986.67286.67286.67286.672
Gross Profit Ratio 0.7470.7380.7470.7610.7430.7480.7460.760.7460.7290.730.7510.750.7250.7570.7180.790.810.8030.7840.780.7980.7810.7910.7570.7570.7570.757
Reseach & Development Expenses 40.95360.57347.96268.45549.08467.78334.37753.18530.47275.377067.937034.63910.43132.2125.94224.396.89722.0125.46316.0564.77100000
General & Administrative Expenses 134.712178.855136.744187.205135.299177.358102.598115.27787.7980.69580.791100.75975.76883.31480.18392.79448.87269.56253.38470.54743.57952.27125.42119.42312.6812.6812.6812.68
Selling & Marketing Expenses 411.912490.18362.026444.538327.422343.227276.814318.888224.042264.928274.276287.999273.538295.738244.526238.094136.271137.428121.615116.054114.917104.59973.32744.48233.87433.87433.87433.874
SG&A 537.453673.971481.238612.04449.931503.888378.066449.019326.341406.211364.826388.758349.306379.052324.709330.888185.143206.99174.999186.601158.496156.8798.74863.90546.55446.55446.55446.554
Other Expenses -78.216-149.437000000000000000000000-2.305-4.544-4.544-4.544-4.544
Operating Expenses 500.19585.107484.052609.944448.056488.858368.96412.976331.446747.793373.309404.243352.274362.735313.045329.212180.149207.833175.041182.819153.58147.47698.51261.642.0142.0142.0142.01
Operating Income 447.333500.155359.961417.94297.468373.288286.894303.413246.714171.506324.873347.304308.021269.011264.421224.973173.477156.542137.387139.16896.295125.86179.97352.61644.76644.76644.76644.766
Operating Income Ratio 0.3530.340.3210.310.2990.3220.3240.3070.3220.2180.3450.3560.3540.3020.3440.2920.3840.3530.3550.3390.3010.3670.350.3680.3910.3910.3910.391
Total Other Income Expenses Net -13.375-14.057-7.20718.93612.04914.882-5.241-9.908-11.493-17.524-11.519-24.729-13.897-11.275-3.4790.3414.6616.722016.42712.26928.9380.6100000
Income Before Tax 433.958486.098377.605436.876309.517388.17307.691337.819245.917-176.259309.922322.575294.124275.987268.995225.314178.138163.264151.518155.595108.564129.87980.58352.61644.76644.76644.76644.766
Income Before Tax Ratio 0.3420.3310.3370.3250.3120.3350.3470.3420.321-0.2240.3290.3310.3380.310.350.2920.3940.3680.3910.3790.3390.3780.3530.3680.3910.3910.3910.391
Income Tax Expense 32.99847.37429.77548.81913.87745.95962.78553.2948.70320.56349.97860.41158.79753.18369.97951.05432.74134.76530.32835.22317.73636.06321.51714.39510.71410.71410.71410.714
Net Income 399.765436.64347.894386.178296.729339.528250.644289.902208.886-169.65249.47246.339219.014211.426184.816162.129145.397128.499121.19120.37290.82893.81659.06638.22134.05234.05234.05234.052
Net Income Ratio 0.3150.2970.3110.2870.2990.2930.2830.2940.273-0.2160.2650.2530.2520.2370.240.210.3220.290.3130.2930.2840.2730.2590.2670.2980.2980.2980.298
EPS 0.490.540.440.490.370.420.310.360.25-0.20.290.280.250.250.210.170.150.130.120.120.090.120.0790.050.0340.0340.0340.034
EPS Diluted 0.490.540.440.490.370.420.310.360.25-0.20.290.280.250.250.210.170.150.130.120.120.0910.120.0790.050.0340.0340.0340.034
EBITDA 453.509501.95395.556451.921333.967407.277321.433337.499281.29207.525358.83384.104339.604301.601295.859255.72181.801165.875146.643147.499103.194132.03686.11255.83247.69447.69447.69447.694
EBITDA Ratio 0.3580.3410.3530.3360.3360.3520.3630.3420.3670.2640.3810.3940.3910.3390.3850.3310.4020.3740.3790.3590.3220.3850.3770.3910.4170.4170.4170.417